Renaissance of betablocker therapy in patients with myocardial infarction;Renaissance der Betablockertherapie beim Myokardinfarkt

Zeitschrift fur Kardiologie

Volumn 85, Issue 10, 1996, Pages 737-744

  Seidl, K ^a   Hauer, B ^a   Zahn, R ^a   Senges, J ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

betablockers; heart failure; myocardial infarction; sudden cardiac death; ventricular arrhythmia

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL; PROPRANOLOL; SOTALOL;

DRUG EFFICACY; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HUMAN; REVIEW; SUDDEN DEATH;

ADRENERGIC BETA-ANTAGONISTS; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; MYOCARDIAL INFARCTION; SURVIVAL RATE;

EID: 0029847532     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Ablad B, Thorvald B, Björkman JA, Edström T, Olsson G (1991) Role of central nervous beta-adrenoceptors in the prevention of ventricular fibrillation through augmentation of cardiac vagal tone. J Am Coll Cardiol 17:165A
2. Antz M, Cappato R, Kuck KH (1995) Metoprolol versus Sotalol in the treatment of sustained ventricular tachycardia. J Cardio Pharmacology 26:627-635
3. Australia-New Zealand Heart Failure Research Collaborative Group (1995) Effects of carvedilol, a vasodilator-β-blocker, in patients with congestive heart failure due to ischemic heart disease. Circulation 95: 212-218
4. Beckmann ML, Gerber JG, Byyny RL, LoVerde M, Nies AS (1988) Propanolol increases prostacyclin synthesis in patients with essential hypertension. Hypertension 12:582-588
5. Benedict CR, Grahame-Smith DG (1979) Plasmaadrenaline and noradrenaline concentrations, and dopamine beta-hydroxylase activity in myocardial infarction with and without cardiogenic shock. Br Heart J 42:214-220
6. Beta-Blocker Heart Attack Trial Research Group (1982) A randomized trial of propanolol in patients with myocardial infarction: I Mortality results. JAMA 247: 1707-1717
7. Bristow MR, Gilbert EM, Abraham WT, Adams KF, Fowler MB, Hershberger R, Kubo SH, Narahara KA, Ingersoll H for the MOCHA Investigators (1995) Multicenter Oral Carvedilol Heart Failure Assessment (MOCHA): A six-month dose-response evaluation in class II-IV patients. Circulation (Suppl) 92,8:1674
8. CIBIS Investigators (1994) A randomized trial of β-blockade in heart failure: The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 90 (4):1765-1773
9. Colucci WS, Packe M, Bristow MR, Cohn JN, Fowler MB, Gilbert EM, Krueger SK, Adams KF, Hershberger R, Uretsky BF (1995) Carvedilol inhibits clinical progression in patients with mild heart failure. Circulation (Suppl) 92 (8):1884
10. Hjalmarson A, Elmfeldt D, Herlitz J, et al (1981) Effect on mortality of metoprolol in acute myocardial infarction: a double-blind randomized trial. Lancet 2:823-827
11. Hjalmarson A, Herlitz J, Holmberg S, et al (1983) The Goteborg metoprolol trial: effects on mortality and morbidity in acute myocardial infarction. Circulation 67 (Pt 2):126-132
12. ISIS-1 (First International Study of Infarct Survival) Collaborative Group (1986) Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 2:57-66
13. Julian DG, Prescott RJ, Jackson FS, Szekely P (1982) A controlled trial of sotalol for one year after myocardial infarction. Lancet 1:1142-1147
14. Lengfelder W, Rappert-Plößer B, Arendts WK, Scherer J, Senges J (1991) Metoprolol vs Sotalol bei ventrikularen Arrhythmien: Vergleich der Wirksamkeit in niedriger Dosierung. MMW 18:295-299
15. Mason JW (1993) The ESVEM Investigators. A comparison of seven antiarrhythmic drugs and patients with ventricular tachyarrhythmias. N Engl J Med 329:452-458
16. Multicenter International Study (1975) Improvement of prognosis of myocardial infarction by long-term beta-adrenoceptor blockade using practolol. Br Med J 3: 735-740
17. Norris RM, Brown MA, Clarke ED, et al (1984) Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol. Lancet 2:883-886
18. Norwegian Multicenter Study Group (1981) Timolol-induced reduction in mortality and reinfarction in patients surviving myocardial infarction. N Engl J Med 304: 801-807
19. Olsson G, Olden A, Johansson R, Sjögren A, Rehnqvist N (1988) Prognosis after withdrawal of chronic post infarction metoprolol treatment: A 27 year follow-up. Eur Heart J 9:365-372
20. Packer M, Colucci WS, Sackner-Bernstein J, Liag CS, Goldschef DA, Freeman I, Kukin ML, Kinhal V, Udelson JE, Klapholz M, and the PRECISE Study Group (1995) Prospective randomized evaluation of carvedilol on symptoms and exercise tolerance in chronic heart failure: Results of the PRECISE Trial. Circulation (Suppl) 92 (8): 675
21. Rizos I, Senges J, Jauernig R, Lengfelder W, Czygan E, Brachmann J, Kübler W (1984) Differential effects of Sotalol and Metoprolol on induction of paroxysmal supraventricular tachycardia. Am J Cardiol 53:1022-1027
22. Rustige J, Burczyk U, Schiele R, Koch A, Harmjanz D, Senges J (1994) "Das 60-Minuten-Herzinfarktprojekt": Wie häufig werden Betablocker, Acetylsalicylsäure und Nitroglycerin beim akuten Herzinfarkt gegeben? Z Kardiol 83 (Suppl 1):106
23. Ryden L, Arniego R, Arnmar K, et al (1983) A double-blind trial of metoprolol in acute myocardial infarction: effects on ventricular tachycardia. N Engl J Med 308:614-618
24. Schuster S, Burczyk U, Wagner S, Senges J (1995) Initialtherapie beim akuten Myokardinfarkt. Wie häufig können adjuvante Therapeutika zur Lyse gegeben werden? Praktikabilität und Sicherheit. Z Kardiol 84 (Suppl 1):72
25. Seidl K, Hauer B, Schilling I, Senges J (1994) Vergleich zwischen Häufigkeit von Arrhythmierezidiven bei ICD-Patienten in Abhängigkeit der Begleitmedikation: Sotalol vs. Metoprolol. Z Kardiol 83 (Suppl 1): 195
26. Seidl K, Lengfelder W, Senges J (1992) Der plötzliche Herztod - pathobiologisches Modell und Risikostratifikation. Klinikarzt 21; Nr. 3:114-128
27. Senges J, Lengfelder W, Jauernig R, Czygan E, Brachmann J, Rizos I, Cobbe S, Kübler W (1984) Electrophysiologic testing in assessment of therapy with sotalol for sustained ventricular tachycardia. Circulation 69 (3):577-584
28. Siebels J, Cappato R, Rüppel R, Schneider MAE, Kuck KH (1993) ICD versus drugs in cardiac arrest survivors: preliminary results of the cardiac arrest study Hamburg. PACE 16:552-558
29. SOLVD investigators (1991) Effect of angiotensin converting enzyme inhibitor enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 325:293-302
30. Steinbeck G, Andresen D, Bach P, Haberl R, Oeff M, Hoffmann E, von Leitner ER (1992) A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias. New Engl J Med 14:987-992
31. Steinbeck G, Hoffmann E, Bach P, Haberl R (1990) Intraindividual comparison of sotalol and metoprolol in patients with sustained ventricular tachycardia and coronary artery disease. In The New Frontiers of Arrhythmias 27-31
32. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989) Preliminary report: effect of encainide and flecainide on mortality in a randomized study of arrhythmia suppression after myocardial infarction. N Engl J Med 321:406-412
33. The MIAMI Trial Research Group (1985) Metoprolol in acute myocardial infarction (MIAMI): a randomised placebo-controlled international trial. Eur Heart J 6: 199-226
34. TIMI Study Group (1989) Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial. N Engl J Med 320:618-627
35. Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjalmarson A, for the Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group (1993) Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 342:1441-1446
36. Willich SN, Linderer T, Wegschneider K, Leizorovicz A, Alamercery I, Schröder R, and the ISAM Study Group (1989) Increased morning incidence of myocardial infarction in the ISAM study: Absence with prior β-adrenergic blockade. Circulation, 80:853-858
37. Yusuf S, Sleight P, Rossi P (1983) Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction. Circulation 67 (Suppl 1):32-41
38. Yusuf S, Sleight P, Held P, McMahon S (1990) Routine medical management of acute myocardial infarction: lessons from overviews of recent randomized controlled trials. Circulation 82 (Suppl II):117-134